FacultyFaculty/Author Profile
David B. Feirstein

David B. Feirstein

Kirkland & Ellis LLP

New York, NY, USA

David Feirstein’s practice concentrates on mergers and acquisitions, corporate and securities law matters and corporate governance. David is recognized in Chambers USA: America’s Leading Lawyers for Business in 2016, which said “he is a superstar; he is incredibly smart and very efficient.” He was also recognized in 2016 and 2014 as a “Rising Star” by Law360 for Mergers & Acquisitions, in The Legal 500 U.S. for M&A: Large Deals ($1bn+) in 2015 and by Super Lawyers for his corporate practice.

David also teaches a class as an adjunct professor at NYU Law on negotiating corporate transactions.

Representative Matters

David has advised clients on numerous significant matters, including the following:

  • Micro Focus International plc in its pending $8.8 billion “Reverse Morris Trust” acquisition of Hewlett Packard Enterprise Company’s software business
  • Celator Pharmaceuticals in its $1.5 billion sale to Jazz Pharmaceuticals
  • Nexstar Broadcasting Group in connection with its unsolicited takeover proposal for Media General in the face of Media General’s proposed acquisition of Meredith Corp., resulting in Nexstar’s pending $4.6 billion acquisition of Media General and the termination of the proposed merger transaction between Meredith and Media General
  • IGATE Corporation in its $4 billion sale to Cap Gemini
  • Burger King Worldwide Inc. in its $13.3 billion merger transaction with Tim Hortons Inc.
  • Infineon Technologies AG in its $3 billion acquisition of International Rectifier Corporation
  • Lazard as financial advisor to Reynolds American in its $27.4 billion acquisition of Lorillard
  • Beechcraft in its $1.4 billion sale of the company to Textron Inc.
  • rue21, inc. in the $1.1 billion sale of the company to Apax Partners
  • 3G Capital Partners Ltd. in its $28.0 billion acquisition, along with Berkshire Hathaway Inc., of H. J. Heinz Company
  • Clearwire Corporation in Sprint’s acquisition of the stake in Clearwire which Sprint did not already own, implying a $14 billion enterprise value for Sprint and the unsolicited competing offer for Clearwire by DISH Networks
  • Bristol-Myers Squibb in its $7 billion acquisition of Amylin Pharmaceuticals and joint collaboration with AstraZeneca plc
  • PVH in its $3 billion acquisition of Tommy Hilfiger
  • MetLife in the recapitalization and split-off of its less than wholly owned subsidiary, RGA
  • ConocoPhillips in its multi-billion dollar oil sands joint venture with EnCana
  • ConocoPhillips in its $35 billion acquisition of Burlington Resources


New York University School of Law, J.D., 2005

  • magna cum laude
  • Order of the Coif
  • NYU Journal of Law and Business, Founding Board Member and Projects Editor

University of Pennsylvania, B.A., Political Science, 2000 

Admissions & Qualifications

New York


  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.